Photocure ASA, the bladder cancer company, announces that it has entered into a strategic agreement with Richard Wolf GmbH to develop and commercialize a next-generation 4K LED high-definition (HD) ...
Mabwell, an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been approved by the NMPA to enter phase II clinical ...
Human "Intelligence" in the form of qualified human resources has been the key component in driving the growth of the pharma industry domains. The industry has been a "blessed" industry with a vast ...
US FDA grants orphan drug designation to Mabwell’s self-developed novel B7-H3-targeting ADC, 7MW3711
Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced that its self-developed novel B7-H3-targeting ADC has been granted Orphan Drug Designation (ODD) by the US ...
A recent study conducted at All India Institute of Medical Sciences (AIIMS), New Delhi, has demonstrated that Yoga has the potential to substantially enhance the well-being of individuals suffering ...
Unicorn India Ventures, a deep tech focused fund house, which is currently raising its third fund of Rs. 1,000 crore, has announced a partial exit from neo diagnostics startups Sascan Meditech. UIV ...
Canadian CRO MHICC selects ArisGlobal’s LifeSphere MultiVigilance and Reporting & Analytics to advance its solutions: Boston, Massachusetts Wednesday, July 17, 2024, 16:00 Hrs [ ...
The Maharashtra State Pharmacy Council (MSPC) has recently made a proposal to the Pharmacy Council of India (PCI) that, similar to the prefix, ‘Dr’, used by medical professionals like physicians, ...
Kyverna Therapeutics, Inc. (Kyverna), a patient-centred, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced the ...
Positrigo, a Swiss based company developing nuclear medical imaging devices to advance functional brain imaging, has achieved a significant milestone with the US Food and Drug Administration (FDA) ...
ViiV Healthcare to present data from largest head-to-head randomised trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024: London, UK Wednesday, July 17, 2 ...
CordenPharma invests €900 million in transformational peptide platform expansion in USA & Europe: Basel, Switzerland Wednesday, July 17, 2024, 10:00 Hrs [IST] CordenPharma, a CD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback